Spectral AI seeks FDA approval for its AI tool that predicts burn wound healing outcomes.

Spectral AI has submitted a marketing clearance application to the FDA for its new DeepView System, an AI-driven tool for predicting burn wound healing. Using multispectral imaging and AI, the system aims to assist doctors in making better clinical decisions and improving patient outcomes. This is a significant step for the company as it seeks to bring this innovative diagnostic tool to U.S. markets.